GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment of severe asthma characterised by an… [+7237 chars]
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma - GSK
SWIFT data included reduction in exacerbations requiring hospitalisation and/or emergency department visits with depemokimab.
Source:Gsk.com
Published:
Related News
Stock Market Today: Dow, S&P 500, Nasdaq climb as stocks rebound from last week's losses; gold and silver surge further - MarketWatch
Stocks were climbing on Monday with the Fed expected to hold rates steady on Wednesday and big tech earnings on tap.
MarketWatch•Joseph Adinolfi, Myra P. Saefong, Jules Rimmer, Joy Wiltermuth, Steve Goldstein
Target's incoming CEO calls Minneapolis violence 'incredibly painful,' does not mention Trump or shootings by federal agents - CNBC
More than 60 Minnesota business leaders, including Fiddelke, signed a letter on Sunday calling for an "immediate deescalation of tensions."
CNBC•Melissa Repko
Microsoft announces powerful new chip for AI inference - TechCrunch
Maia comes equipped with over 100 billion transistors, delivering over 10 petaflops in 4-bit precision and approximately 5 petaflops of 8-bit performance — a substantial increase over its predecessor.
TechCrunch•Lucas Ropek